Australia markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
21.00+0.89 (+4.43%)
At close: 04:00PM EDT
20.90 -0.10 (-0.48%)
After hours: 07:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
380,229
365,978
353,874
306,486
251,247
Cost of revenue
5,263
5,281
5,582
5,504
5,215
Gross profit
374,966
360,697
348,292
300,982
246,032
Operating expenses
Research development
112,962
113,864
114,764
89,017
75,247
Selling general and administrative
130,396
122,356
105,326
100,359
81,289
Total operating expenses
243,358
236,220
220,090
189,376
156,536
Operating income or loss
131,608
124,477
128,202
111,606
89,496
Income before tax
131,942
125,006
131,602
116,676
92,153
Income tax expense
20,098
12,494
25,591
22,495
16,743
Income from continuing operations
111,844
112,512
106,011
94,181
75,410
Net income
111,844
112,512
106,011
94,181
75,410
Net income available to common shareholders
111,844
112,512
106,011
94,181
75,410
Basic EPS
-
-
0.92
0.82
0.65
Diluted EPS
-
-
0.85
0.77
0.60
Basic average shares
-
-
115,412
114,349
115,343
Diluted average shares
-
-
124,194
122,566
126,688
EBITDA
-
127,544
130,439
113,777
89,732